Acadian Asset Management LLC Lexicon Pharmaceuticals, Inc. Transaction History

Acadian Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$4.12 - $5.87 $1.9 Million - $2.71 Million	-462,296 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$3.45 - $9.09 $4.25 Million - $11.2 Million	-1,231,739 Reduced 72.71%	462,296 $2.71 Million
Q4 2020 Feb 11, 2021	SELL	$1.05 - $3.67 $168,288 - $588,209	-160,275 Reduced 8.64%	1,694,035 $5.79 Million
Q3 2020 Nov 09, 2020	BUY	$1.44 - $2.1 $275,592 - $401,906	191,384 Added 11.51%	1,854,310 $2.67 Million
Q2 2020 Aug 12, 2020	BUY	$1.75 - $2.3 $1.03 Million - $1.35 Million	586,865 Added 54.54%	1,662,926 $3.32 Million

Q1 2020 May 11, 2020	BUY	$1.8 - $4.28 $1.64 Million - $3.9 Million	911,113 Added 552.36%	1,076,061 $2.1 Million
Q4 2019 Feb 06, 2020	BUY	$3.16 - $5.15 $521,235 - $849,482	164,948 New	164,948 $685,000

122

159M

2.11M

412K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $315M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.